9 research outputs found

    Réseaux metallo-organiques et complexes de dendrimères luminescents à base de lanthanides pour imagerie optique

    No full text
    Les composés à base de lanthanides luminescents possèdent des propriétés uniques offrant de nombreux avantages pour l’étude de problèmes biologiques et pour le diagnostic. Ils résistent notamment à la photodécomposition, possèdent des temps de vie de luminescence longs ainsi que des bandes d’émissions étroites qui ne se recouvrent pas. De plus, certains lanthanides émettent dans le proche infrarouge, ce qui les rend particulièrement intéressants pour des applications d'’imagerie in vivo. De part l’interdiction des transitions f → f, les cations lanthanides ont des coefficients d’extinction très faibles. C’est la raison pour laquelle, il est nécessaire d’utiliser un ou plusieurs sensibilisateur(s) (comme un chromophore organique) pour exciter le lanthanide par « effet antenne ». Nous proposons ici de nouveaux composés émettant dans le proche infrarouge dont la structure permet d’incorporer une densité importante de lanthanides et de sensibilisateurs par unite de volume : i) les nano-MOF Yb-PVDC-3 constitués de chromophores dérivés de dicarboxylates de phenylènevinylène qui sensibilisent les cations Yb3+ du réseau. ii) les complexes formés avec des ligands dendrimères dérivés de polyamidoamine de génération 3 capables de sensibiliser 8 lanthanides (Eu3+, Yb3+, Nd3+) par le biais de 32 antennes dérivées du groupe 1,8-naphthalimide. La caractérisation physique, photophysique et la biocompatibilité de ces composés ont été réalisées. Ils ont montré une bonne stabilité dans différents environnements. Leur faible cytotoxicité a permis d’obtenir des images de microscopie proche infrarouge sur cellules vivantes. La preuve de principe que les nano-MOFs et les dendrimères complexant des lanthanides peuvent être utilisés comme rapporteurs luminescents in cellulo et in vivo a été ici établie. Les résultats obtenus valident la stratégie d’utiliser ce type de matériel pour augmenter le nombre de photons émis par unité de volume afin d’obtenir une meilleure sensibilité de détection.Unique properties of luminescent lanthanides reporters explain their emergence for bioanalytical and optical imaging applications. Lanthanide ions possess long emission lifetimes, a good resistance to photodecomposition and sharp emission bands that do not overlap. In addition, several lanthanides emit in the near infrared (NIR) region of the electromagnetic spectrum making them very interesting for in vivo imaging. Free lanthanide cations have low extinction coefficients due to the forbidden nature of the f → f transition. Therefore, lanthanides must be sensitized using a photonic converter such as an organic chromophore through the “antenna effect". We report here new near-infrared emitting compounds whose structure allows to incorporate a high density of lanthanide cations and sensitizers per unit volume: i) nano-MOF Yb-PVDC-3 based on Yb3+ sensitized by phenylenevinylene dicarboxylates. ii) polymetallic dendrimer complexes formed with derivatives of new generation-3 polyamidoamine dendrimers. In these complexes, 8 lanthanide ions (Eu3+, Yb3+, Nd3+) can be sensitized by the 32 antenna derived from 1,8-naphthalimide. These two families of compounds were fully characterised for their physical, photophysical properties as well as for their biological respective compatibilities. They are stable in various media and their low cytotoxicity and emission of a sufficient number of photons are suitable for near-infrared live cell imaging. One of the main goal outcomes of this work is the establishment of the proof of principle that nano- MOFs and lanthanide derived dendrimers can be used for the sensitization of NIR emitting lanthanides to create a new generation of NIR optical imaging agents suitable for both in cellulo and in vivoapplications.The present work also validates the efficiency of the strategy to use both types of nanoscale systems described here to increase the number of emitted photons per unit volume for an improved detection sensitivity and to compensate for low quantum yields

    Réseaux metallo-organiques et complexes de dendrimères luminescents à base de lanthanides pour imagerie optique

    No full text
    Les composés à base de lanthanides luminescents possèdent des propriétés uniques offrant de nombreux avantages pour l étude de problèmes biologiques et pour le diagnostic. Ils résistent notamment à la photodécomposition, possèdent des temps de vie de luminescence longs ainsi que des bandes d émissions étroites qui ne se recouvrent pas. De plus, certains lanthanides émettent dans le proche infrarouge, ce qui les rend particulièrement intéressants pour des applications d' imagerie in vivo. De part l interdiction des transitions f -> f, les cations lanthanides ont des coefficients d extinction très faibles. C est la raison pour laquelle, il est nécessaire d utiliser un ou plusieurs sensibilisateur(s) (comme un chromophore organique) pour exciter le lanthanide par effet antenne . Nous proposons ici de nouveaux composés émettant dans le proche infrarouge dont la structure permet d incorporer une densité importante de lanthanides et de sensibilisateurs par unite de volume : i) les nano-MOF Yb-PVDC-3 constitués de chromophores dérivés de dicarboxylates de phenylènevinylène qui sensibilisent les cations Yb3+ du réseau. ii) les complexes formés avec des ligands dendrimères dérivés de polyamidoamine de génération 3 capables de sensibiliser 8 lanthanides (Eu3+, Yb3+, Nd3+) par le biais de 32 antennes dérivées du groupe 1,8-naphthalimide. La caractérisation physique, photophysique et la biocompatibilité de ces composés ont été réalisées. Ils ont montré une bonne stabilité dans différents environnements. Leur faible cytotoxicité a permis d obtenir des images de microscopie proche infrarouge sur cellules vivantes. La preuve de principe que les nano-MOFs et les dendrimères complexant des lanthanides peuvent être utilisés comme rapporteurs luminescents in cellulo et in vivo a été ici établie. Les résultats obtenus valident la stratégie d utiliser ce type de matériel pour augmenter le nombre de photons émis par unité de volume afin d obtenir une meilleure sensibilité de détection.Unique properties of luminescent lanthanides reporters explain their emergence for bioanalytical and optical imaging applications. Lanthanide ions possess long emission lifetimes, a good resistance to photodecomposition and sharp emission bands that do not overlap. In addition, several lanthanides emit in the near infrared (NIR) region of the electromagnetic spectrum making them very interesting for in vivo imaging. Free lanthanide cations have low extinction coefficients due to the forbidden nature of the f -> f transition. Therefore, lanthanides must be sensitized using a photonic converter such as an organic chromophore through the antenna effect". We report here new near-infrared emitting compounds whose structure allows to incorporate a high density of lanthanide cations and sensitizers per unit volume: i) nano-MOF Yb-PVDC-3 based on Yb3+ sensitized by phenylenevinylene dicarboxylates. ii) polymetallic dendrimer complexes formed with derivatives of new generation-3 polyamidoamine dendrimers. In these complexes, 8 lanthanide ions (Eu3+, Yb3+, Nd3+) can be sensitized by the 32 antenna derived from 1,8-naphthalimide. These two families of compounds were fully characterised for their physical, photophysical properties as well as for their biological respective compatibilities. They are stable in various media and their low cytotoxicity and emission of a sufficient number of photons are suitable for near-infrared live cell imaging. One of the main goal outcomes of this work is the establishment of the proof of principle that nano- MOFs and lanthanide derived dendrimers can be used for the sensitization of NIR emitting lanthanides to create a new generation of NIR optical imaging agents suitable for both in cellulo and in vivoapplications.The present work also validates the efficiency of the strategy to use both types of nanoscale systems described here to increase the number of emitted photons per unit volume for an improved detection sensitivity and to compensate for low quantum yields.ORLEANS-SCD-Bib. electronique (452349901) / SudocSudocFranceF

    Efficient red light photo-uncaging of active molecules in water upon assembly into nanoparticles

    No full text
    International audienceWe introduce a means of efficiently photo-uncaging active compounds from amino-1,4-benzoquinone in aqueous environments. Aqueous photochemistry of this photocage with one-photon red light is typically not efficient unless the photocaged molecules are allowed to assemble into nanoparticles. A variety of biologically active molecules were functionalized with the photocage and subsequently formulated into water-dispersible nanoparticles. Red light irradiation through various mammalian tissues achieved efficient photo-uncaging. Co-encapsulation of NIR fluorescent dyes and subsequent photomodulation provides a NIR fluorescent tool to assess both particle location and successful photorelease

    Complexes de lanthanides à base de dendrimères

    No full text
    The present invention relates to a complex comprising at least one dendrimer and at least one lanthanide, in which the dendrimer comprises a unit of formula (I), wherein: C1 is a group with a valency of 4 of formula >N-CH2-CH2-NN-CH2-CH2-N<; - A1, A2 et A3 sont des groupes de formule -(CH2)2-C(O)-NH-(CH2)2-; ledit motif de formule (I) étant relié de façon covalente à au moins une antenne qui absorbe à une longueur d'onde allant de 500 nm à 900 nm

    Short Soluble Coumarin Crosslinkers for Light-Controlled Release of Cells and Proteins from Hydrogels

    No full text
    Materials that degrade or dissociate in response to low power light promise to enable on-demand, precisely localized delivery of drugs or bioactive molecules in living systems. Such applications remain elusive because few materials respond to wavelengths that appreciably penetrate tissues. The photocage bromohydroxycoumarin (Bhc) is efficiently cleaved upon low-power ultraviolet (UV) and near-infrared (NIR) irradiation through one- or two-photon excitation, respectively. We have designed and synthesized a short Bhc-bearing crosslinker to create light-degradable hydrogels and nanogels. Our crosslinker breaks by intramolecular cyclization in a manner inspired by the naturally occurring ornithine lactamization, in response to UV and NIR light, enabling rapid degradation of polyacrylamide gels and release of small hydrophilic payloads such as an ∼10 nm model protein and murine mesenchymal stem cells, with no background leakage

    Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia

    Get PDF
    International audienceHypoxia-inducing pathologies as cancer develop pathologic and inefficient angiogenesis which rules tumor facilitating microenvironment, a key target for therapy. As such, the putative ability of endothelial precursor cells (EPCs) to specifically home to hypoxic sites of neovascularization prompted to design optimized, site-specific, cell-mediated, drug-/gene-targeting approach. Thus, EPC lines were established from aorta-gonad-mesonephros (AGM) of murine 10.5 dpc and 11.5 dpc embryo when endothelial repertoire is completed. Lines representing early endothelial differentiation steps were selected: MAgEC10.5 and MagEC11.5. Distinct in maturation, they differently express VEGF receptors, VE-cadherin and chemokine/receptors. MAgEC11.5, more differentiated than MAgEC 10.5, displayed faster angiogenesis in vitro, different response to hypoxia and chemokines. Both MAgEC lines cooperated to tube-like formation with mature endothelial cells and invaded tumor spheroids through a vasculogenesis-like process. In vivo, both MAgEC-formed vessels established blood flow. Intravenously injected, both MAgECs invaded Matrigel(TM)-plugs and targeted tumors. Here we show that EPCs (MAgEC11.5) target tumor angiogenesis and allow local overexpression of hypoxia-driven soluble VEGF-receptor2 enabling drastic tumor growth reduction. We propose that such EPCs, able to target tumor angiogenesis, could act as therapeutic gene vehicles to inhibit tumor growth by vessel normalization resulting from tumor hypoxia alleviation
    corecore